Konstantin V. Balakin - Pharmaceutical Data Mining: Approaches and Applications for Drug Discovery
-25%

Pharmaceutical Data Mining: Approaches and Applications for Drug Discovery

Konstantin V. Balakin

ISBN: 9780470196083
Vydavatelství: Wiley
Rok vydání: 2010
Vazba: Hardback
Počet stran: 562
Dostupnost: Skladem

Původní cena: 4 330 Kč
Výstavní cena: 3 248 Kč(t.j. po slevě 25%)
(Cena je uvedena včetně 10% DPH)
Katalogová cena: 103 GBP

Nárok na dopravu zdarma
Přidat do wishlistu
Zpět Tisknout
Koupit
Leading experts illustrate how sophisticated computational data mining techniques can impact contemporary drug discovery and development In the era of post–genomic drug development, extracting and applying knowledge from chemical, biological, and clinical data is one of the greatest challenges facing the pharmaceutical industry. Pharmaceutical Data Mining brings together contributions from leading academic and industrial scientists, who address both the implementation of new data mining technologies and application issues in the industry. This accessible, comprehensive collection discusses important theoretical and practical aspects of pharmaceutical data mining, focusing on diverse approaches for drug discovery including chemogenomics, toxicogenomics, and individual drug response prediction. The five main sections of this volume cover: A general overview of the discipline, from its foundations to contemporary industrial applications Chemoinformatics–based applications Bioinformatics–based applications Data mining methods in clinical development Data mining algorithms, technologies, and software tools, with emphasis on advanced algorithms and software that are currently used in the industry or represent promising approaches In one concentrated reference, Pharmaceutical Data Mining reveals the role and possibilities of these sophisticated techniques in contemporary drug discovery and development. It is ideal for graduate–level courses covering pharmaceutical science, computational chemistry, and bioinformatics. In addition, it provides insight to pharmaceutical scientists, principal investigators, principal scientists, research directors, and all scientists working in the field of drug discovery and development and associated industries.